2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO5] Mini-Oral Session 5　Hepatobiliary / Pancreatic Cancer 2（HCC, Pancreatic Cancer）
【E】

Thu. Feb 17, 2022 1:20 PM - 2:10 PM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Hiroshi Imaoka（Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East），Yasushi Kojima（Department of Gastroenterology, National Center For Global Health and Medicine）

[MO5-2] Cabozantinib may enhance efficacy of anti-PD-1 therapy in hepatocellular carcinoma through suppression of MDSCs

○Da-Liang Ou1, Li Lin1, Chia-Lang Hsu1,2, Cheng-Zhe Jian1, Bin-Shyun Lee1, Ann-Lii Cheng1,3,4, Chiun Hsu1,3,4 (1.Graduate Institute of Oncology, College of Medicine, National Taiwan University, 2.Department of Medical Research, National Taiwan University Hospital, 3.National Taiwan University Cancer Center, 4.Department of Oncology, National Taiwan University Hospital)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password